Effects of Upper Airway Muscle Training on OSA



Status:Recruiting
Conditions:Insomnia Sleep Studies, Pulmonary
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 79
Updated:4/21/2016
Start Date:August 2015
End Date:June 2017
Contact:Robert Owens, MD
Email:rowens@ucsd.edu
Phone:619-471-9505

Use our guide to learn which trials are right for you!

Effects of Upper Airway Muscle Training on Obstructive Sleep Apnea (OSA)

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent collapse of
the upper airway during sleep. OSA patients have a small upper airway that is kept patent
during wakefulness by a compensatory increase in upper airway (UA) dilator muscle (e.g.
genioglossus) activity. At sleep onset this compensation is reduced or lost, resulting in
upper airway narrowing or collapse. Previous studies of upper airway muscle training showed
variable results on OSA, but so far there has not been any practical, long-term, systematic
upper airway muscle training developed or studied as the treatment of OSA. In theory,
strengthening the upper airway muscle with exercise training in theory helps maintain a
patent airway during sleep. Therefore, investigators aim to test the hypothesis: 1) UA
muscle training can improve sleep apnea in some patients with OSA, including those already
receiving treatment with PAP or oral appliance therapy. 2) Muscle training is a viable
therapy for a definable subset of OSA patients. Investigators hypothesize that patients with
OSA who have mild or moderately compromised upper airway anatomy will benefit the most.
3)There will be a positive association between the changes in muscle function and
improvement in OSA severity.

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent collapse of
the upper airway during sleep, which leads to recurrent arousal and subsequent daytime
sleepiness. The most commonly accepted reason for the initiation of obstructive respiratory
events in OSA is that patients have a small upper airway that is kept patent during
wakefulness by a compensatory increase in upper airway dilator muscle (e.g. genioglossus)
activity. At sleep onset this compensation is reduced or lost, resulting in upper airway
narrowing or collapse.

Upper airway (UA) muscle training appears to have some benefit in OSA with improvement in
the AHI, although the current data shows variable results, particularly when publication
bias is taken into account. Many remain skeptical about these data based on clinical
experience and prior negative studies (which remain largely unpublished). Moreover, previous
positive studies involved exercises that are usually impractical to be continued in the
long-term.

Therefore, investigators will undertake a rigorous assessment of a practical UA muscle
training on OSA. Investigators will recruit patients with OSA that are wither
unable/unwilling to use CPAP, as well as those who are already on treatment with PAP or oral
appliances. The exercises include 4 steps: step 1 is to put on an individualized fitted oral
retainer device to guide the exercise; step 2 is to push the tongue towards the hard palate
to press the movable part of the oral retainer device for 4 minutes; step 3 is to touch the
hard palate using the middle part of the tongue, hold for 10 seconds and repeat it for 4
minutes; step 4 is to remove the retainer device and brush the tongue gently on both sides
for 2 minute. The exercise will take 20 minutes a day (10 minutes in the morning and 10
minutes in the afternoon/evening).

Investigators will study the effect of upper airway (UA) muscle training on OSA severity,
muscle strengh and endurance. Investigators aim to determine the characteristics of OSA
patients most likely to benefit from UA muscle training and the association between changes
in muscle function and OSA severity.

Inclusion Criteria:

- Prior diagnosis of OSA with AHI>10 events/hr.

- PAP group: subjects who have been on PAP treatment for at least 3 month, with good
compliance (at least 4 hours a day and use PAP for >70% of the time).

- Untreated group: untreated subjects with generally mild OSA as defined by AHI<20
events/hr and nadir SaO2>70%. Additionally, investigators will also recruit OSA
subjects of all severities who have previously tried but are not currently using PAP.

- Oral appliance treatment group: subjects have residual AHI >10 events/hr with oral
appliance therapy.

Exclusion Criteria:

- In those with untreated sleep apnea, severe sleepiness with current Epworth
Sleepiness Scale (ESS) > 18 or history of motor vehicle accident due to obstructive
sleep apnea

- Taking medications classified as a muscle relaxant

- Pregnant women.

- Psychiatric disorder, other than mild and controlled depression; e.g. schizophrenia,
bipolar disorder, major depression, panic or anxiety disorders.

- Current smokers, alcohol (>3oz/day) or use of illicit drugs.

- More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day.

- Unstable cardiac disease (e.g. congestive heart failure)

- Pulmonary disease (apart from well controlled mild asthma and OSA)

- Systemic neuromuscular disease

- Other systemic disease that affects breathing (e.g. stroke) or those with expected
survival < 1 year.

- Poor oral condition, including: active periodontal disease, loose or broken teeth,
lack of eight teeth in each arch, active TMJ dysfunction

- Known allergy to oral appliance components
We found this trial at
1
site
San Diego, California 92093
Principal Investigator: Robert Owens, M.D.
Phone: 619-471-9484
?
mi
from
San Diego, CA
Click here to add this to my saved trials